PMID- 12931039 OWN - NLM STAT- MEDLINE DCOM- 20040324 LR - 20221207 IS - 0301-0163 (Print) IS - 0301-0163 (Linking) VI - 60 IP - 3 DP - 2003 TI - Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents. PG - 121-6 AB - OBJECTIVE: We report the presentation and 5-year follow-up of 89 African-American (AA) and Caribbean-Hispanic (CH) youths with type 2 diabetes mellitus (T2DM) followed at the Montefiore Medical Center, Bronx, N.Y., USA, from 1990 to 2000. METHODS: The medical records of 89 patients with T2DM diagnosed between 1990 and 2000 were reviewed. RESULTS: Over a 10-year period, the number of pediatric patients less than 18 years of age diagnosed with T2DM at the Montefiore Medical Center increased tenfold. At presentation, the mean age was 14 +/- 2.3 years, the mean body mass index (BMI) was 34.4 +/- 9 kg/m(2), the female/male ratio was 1.6:1, and all these patients were pubertal. Acanthosis nigricans was present in 89% of the patients, polyuria and polydipsia occurred in 48%, weight loss occurred in 22%, and nearly 30% of the patients were asymptomatic at diagnosis. Diabetic ketoacidosis occurred in 5 patients. By 5 years after diagnosis, 45% of the patients were able to maintain an HgbA1C <7% with oral medications (metformin and/or glipizide); 18% required insulin (<0.4 U/kg/day) in addition to oral medications, and 37% did not require any medication. The mean insulin level, BMI and HgbA1C at the time of diagnosis did not predict treatment requirements for 3 years after diagnosis. CONCLUSIONS: Because the incidence of T2DM is increasing in adolescents, the natural history and optimal therapy for adolescents with T2DM need to be established. CI - Copyright 2003 S. Karger AG, Basel FAU - Grinstein, Gabriela AU - Grinstein G AD - Department of Pediatrics, Division of Pediatric Endocrinology, Albert Einstein College of Medicine, Bronx, NY, USA. FAU - Muzumdar, Radhika AU - Muzumdar R FAU - Aponte, Leonor AU - Aponte L FAU - Vuguin, Patricia AU - Vuguin P FAU - Saenger, Paul AU - Saenger P FAU - DiMartino-Nardi, Joan AU - DiMartino-Nardi J LA - eng PT - Journal Article PL - Switzerland TA - Horm Res JT - Hormone research JID - 0366126 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) RN - 9100L32L2N (Metformin) SB - IM MH - Adolescent MH - *Black or African American MH - Blood Glucose/analysis MH - Body Mass Index MH - Caribbean Region/ethnology MH - Child MH - Diabetes Mellitus/epidemiology MH - Diabetes Mellitus, Type 2/complications/*drug therapy/*ethnology/pathology MH - Female MH - Follow-Up Studies MH - Glycated Hemoglobin/metabolism MH - *Hispanic or Latino MH - Humans MH - Hypoglycemic Agents/therapeutic use MH - Insulin/blood/therapeutic use MH - Male MH - Metformin/therapeutic use MH - Obesity MH - Prevalence EDAT- 2003/08/22 05:00 MHDA- 2004/03/25 05:00 CRDT- 2003/08/22 05:00 PHST- 2002/06/17 00:00 [received] PHST- 2003/05/20 00:00 [accepted] PHST- 2003/08/22 05:00 [pubmed] PHST- 2004/03/25 05:00 [medline] PHST- 2003/08/22 05:00 [entrez] AID - 72523 [pii] AID - 10.1159/000072523 [doi] PST - ppublish SO - Horm Res. 2003;60(3):121-6. doi: 10.1159/000072523.